130 related articles for article (PubMed ID: 23210906)
1. A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.
Adler A; Baraniak A; Izdebski R; Fiett J; Gniadkowski M; Hryniewicz W; Salvia A; Rossini A; Goossens H; Malhotra S; Lerman Y; Elenbogen M; Carmeli Y;
Clin Microbiol Infect; 2013 Feb; 19(2):E51-8. PubMed ID: 23210906
[TBL] [Abstract][Full Text] [Related]
2. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
[TBL] [Abstract][Full Text] [Related]
3. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
4. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.
Adler A; Baraniak A; Izdebski R; Fiett J; Salvia A; Samso JV; Lawrence C; Solomon J; Paul M; Lerman Y; Schwartzberg Y; Mordechai E; Rossini A; Fierro J; Lammens C; Malhotra-Kumar S; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M; Carmeli Y;
Clin Microbiol Infect; 2014 Aug; 20(8):O516-23. PubMed ID: 24450778
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66).
Wu JJ; Chen HM; Ko WC; Wu HM; Tsai SH; Yan JJ
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):169-75. PubMed ID: 17913434
[TBL] [Abstract][Full Text] [Related]
6. Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 beta-lactamases at 2 hospitals in Taiwan.
Wu LT; Wu HJ; Chung JG; Chuang YC; Cheng KC; Yu WL
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):89-94. PubMed ID: 16406185
[TBL] [Abstract][Full Text] [Related]
7. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre.
Adler A; Gniadkowski M; Baraniak A; Izdebski R; Fiett J; Hryniewicz W; Malhotra-Kumar S; Goossens H; Lammens C; Lerman Y; Kazma M; Kotlovsky T; Carmeli Y;
Clin Microbiol Infect; 2012 Dec; 18(12):E497-505. PubMed ID: 22963432
[TBL] [Abstract][Full Text] [Related]
8. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
Endimiani A; Luzzaro F; Brigante G; Perilli M; Lombardi G; Amicosante G; Rossolini GM; Toniolo A
Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
[TBL] [Abstract][Full Text] [Related]
9. Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum β-lactamase in spinal cord injury patients with recurrent bacteriuria.
Cremet L; Bemer P; Rome J; Juvin ME; Navas D; Bourigault C; Guillouzouic A; Caroff N; Lepelletier D; Asseray N; Perrouin-Verbe B; Corvec S
Scand J Infect Dis; 2011 Dec; 43(11-12):957-61. PubMed ID: 21888562
[TBL] [Abstract][Full Text] [Related]
10. Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak.
Löhr IH; Rettedal S; Natås OB; Naseer U; Oymar K; Sundsfjord A
J Antimicrob Chemother; 2013 May; 68(5):1043-8. PubMed ID: 23288401
[TBL] [Abstract][Full Text] [Related]
11. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
[TBL] [Abstract][Full Text] [Related]
12. Regional Spread of CTX-M-2-Producing Proteus mirabilis with the Identical Genetic Structure in Japan.
Kato K; Matsumura Y; Yamamoto M; Nagao M; Takakura S; Ichiyama S
Microb Drug Resist; 2017 Jul; 23(5):590-595. PubMed ID: 27834610
[TBL] [Abstract][Full Text] [Related]
13. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
[TBL] [Abstract][Full Text] [Related]
14. Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan.
Kanayama A; Kobayashi I; Shibuya K
Int J Antimicrob Agents; 2015 Feb; 45(2):113-8. PubMed ID: 25182712
[TBL] [Abstract][Full Text] [Related]
15. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
Nicolas-Chanoine MH; Gruson C; Bialek-Davenet S; Bertrand X; Thomas-Jean F; Bert F; Moyat M; Meiller E; Marcon E; Danchin N; Noussair L; Moreau R; Leflon-Guibout V
J Antimicrob Chemother; 2013 Mar; 68(3):562-8. PubMed ID: 23143897
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
Tian SF; Chen BY; Chu YZ; Wang S
Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
[TBL] [Abstract][Full Text] [Related]
17. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
[TBL] [Abstract][Full Text] [Related]
18. Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital.
Biendo M; Thomas D; Laurans G; Hamdad-Daoudi F; Canarelli B; Rousseau F; Castelain S; Eb F
Clin Microbiol Infect; 2005 May; 11(5):395-401. PubMed ID: 15819867
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.
Tinelli M; Cataldo MA; Mantengoli E; Cadeddu C; Cunietti E; Luzzaro F; Rossolini GM; Tacconelli E
J Antimicrob Chemother; 2012 Dec; 67(12):2982-7. PubMed ID: 22865381
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of quinolone resistance determinant qnrA6 among broad- and extended-spectrum beta-lactam-resistant Proteus mirabilis and Morganella morganii clinical isolates with sul1-type class 1 integron association in a Tunisian Hospital.
Mahrouki S; Perilli M; Bourouis A; Chihi H; Ferjani M; Ben Moussa M; Amicosante G; Belhadj O
Scand J Infect Dis; 2013 Aug; 45(8):600-5. PubMed ID: 23746343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
